250 related articles for article (PubMed ID: 29708352)
61. The epidemiology of genital human papillomavirus infection.
Trottier H; Franco EL
Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226
[TBL] [Abstract][Full Text] [Related]
62. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
de Sanjosé S; Bruni L; Alemany L
Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
[TBL] [Abstract][Full Text] [Related]
63. The role of sexual behavior in head and neck cancer: implications for prevention and therapy.
Rettig E; Kiess AP; Fakhry C
Expert Rev Anticancer Ther; 2015 Jan; 15(1):35-49. PubMed ID: 25193346
[TBL] [Abstract][Full Text] [Related]
64. Epidemiology of anogenital warts and cancer.
Franco EL
Obstet Gynecol Clin North Am; 1996 Sep; 23(3):597-623. PubMed ID: 8869948
[TBL] [Abstract][Full Text] [Related]
65. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.
Wang CC; Palefsky JM
Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278
[TBL] [Abstract][Full Text] [Related]
66. Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico.
Ortiz AP; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Tortolero-Luna G; Suárez E; Palefsky J
Papillomavirus Res; 2016 Dec; 2():89-96. PubMed ID: 29074191
[TBL] [Abstract][Full Text] [Related]
67. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
68. Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.
Zou H; Tabrizi SN; Grulich AE; Hocking JS; Bradshaw CS; Cornall AM; Morrow A; Prestage G; Law MG; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2015 Jan; 15(1):65-73. PubMed ID: 25435055
[TBL] [Abstract][Full Text] [Related]
69. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
70. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
71. Prognosis of HPV-Positive and -Negative Oropharyngeal Cancers Depends on the Treatment Modality.
Horáková Z; Slavik M; Veselý K; Budíková M; Kostřica R; Binková H
Klin Onkol; 2019; 32(3):187-196. PubMed ID: 31216850
[TBL] [Abstract][Full Text] [Related]
72. Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus.
Vernon SD; Holmes KK; Reeves WC
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S121-4. PubMed ID: 8547501
[TBL] [Abstract][Full Text] [Related]
73. The epidemiology of human papillomaviruses.
Nyitray AG; Iannacone MR
Curr Probl Dermatol; 2014; 45():75-91. PubMed ID: 24643179
[TBL] [Abstract][Full Text] [Related]
74. Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?
Dillner J; Brown DR
Expert Rev Mol Med; 2004 Apr; 6(9):1-21. PubMed ID: 15096282
[TBL] [Abstract][Full Text] [Related]
75. The role of human papillomavirus in oral squamous cell carcinoma (review).
Gogilashvili K; Shonia N; Burkadze G
Georgian Med News; 2012 Dec; (213):32-6. PubMed ID: 23293230
[TBL] [Abstract][Full Text] [Related]
76. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
Rosenquist K; Wennerberg J; Annertz K; Schildt EB; Hansson BG; Bladström A; Andersson G
Acta Otolaryngol; 2007 Sep; 127(9):980-7. PubMed ID: 17712679
[TBL] [Abstract][Full Text] [Related]
77. Low prevalence of human papillomavirus in oral cavity carcinomas.
Machado J; Reis PP; Zhang T; Simpson C; Xu W; Perez-Ordonez B; Goldstein DP; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
Head Neck Oncol; 2010 Mar; 2():6. PubMed ID: 20226055
[TBL] [Abstract][Full Text] [Related]
78. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
[TBL] [Abstract][Full Text] [Related]
79. Human papillomavirus (HPV) infection in a case-control study of oral squamous cell carcinoma and its increasing trend in northeastern Thailand.
Phusingha P; Ekalaksananan T; Vatanasapt P; Loyha K; Promthet S; Kongyingyoes B; Patarapadungkit N; Chuerduangphui J; Pientong C
J Med Virol; 2017 Jun; 89(6):1096-1101. PubMed ID: 27935063
[TBL] [Abstract][Full Text] [Related]
80. Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma.
Windon MJ; D'Souza G; Waterboer T; Rooper L; Westra WH; Troy T; Pardoll D; Tan M; Yavvari S; Kiess AP; Miles B; Mydlarz WK; Ha PK; Bender N; Eisele DW; Fakhry C
Head Neck; 2020 Aug; 42(8):1954-1962. PubMed ID: 32101350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
